Schedule 13G ownership disclosure

AYTU BIOPHARMA INC

Security class unavailable · CUSIP: 054754874

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,398,776
Percent of class
8.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-21-000116
Form type
SC 13G/A
Filer
AYTU BIOPHARMA, INC
CIK
CIK 1385818
Filed
Feb 12, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub